APA (7th ed.) Citation

Tichá, V., Počíková, Z., Vytlačil, J., & Štěpánová, R. (2022). Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: Results from core and extension parts of the GOLEMS study up to 48 months. BMC.

Chicago Style (17th ed.) Citation

Tichá, Veronika, Zuzana Počíková, Josef Vytlačil, and Radka Štěpánová. Real-world Effectiveness and Safety of Fingolimod in Patients with Multiple sclerosis in the Czech Republic: Results from Core and Extension Parts of the GOLEMS Study Up to 48 months. BMC, 2022.

MLA (9th ed.) Citation

Tichá, Veronika, et al. Real-world Effectiveness and Safety of Fingolimod in Patients with Multiple sclerosis in the Czech Republic: Results from Core and Extension Parts of the GOLEMS Study Up to 48 months. BMC, 2022.